Orkla India IPO GMP Today — Check Full GMP Trend & Listing Gains
Orkla India IPO GMP Today: The buzz around Orkla India IPO GMP today is heating up as the IPO inches to its closing date. Investors are tracking the grey market premium (GMP) closely, and the numbers look promising. Orkla India IPO GMP today, on November 06 stands ₹66, i.e. 9.04% premium over the upper price band.
As Orkla India — known for brands like MTR and Eastern — prepares to list on Dalal Street, the Orkla India IPO is drawing attention not only for its strong brand recall but also for its potential double-digit listing gains. However, while the growing GMP trend suggests optimism, investors must remember that grey market trades are unofficial and speculative.
Here’s a detailed look at the Orkla India IPO GMP today, GMP trend movement, key dates, and what the premium really means for investors ahead of Orkla India’s much-awaited debut.
What is the Orkla India IPO GMP today Live Update & Price Trend?
Latest figures
- The Orkla India IPO GMP today stands at ₹66 per share, which implies ~9.04% premium over the upper band of ₹730.
Trend summary (Day-wise snapshot)
| Date | IPO GMP (₹) | GMP Trend | Estimated Listing Gain (%) |
|---|
| 6 Nov | ₹66 | 🔽 GMP Softened | 9.04% |
| 5 Nov | ₹70 | 🔽 GMP Steady | 9.58% |
| 4 Nov | ₹70 | 🔽 GMP Softened | 9.58% |
| 3 Nov | ₹80 | 🔽 GMP Softened | 10.96% |
| 1 Nov | ₹92 | 🔼 GMP Rising | 12.60% |
| 31 Oct | ₹75 | 🔼 GMP Rising | 10.27% |
* Using upper issue band of ₹730 + GMP = estimated listing price.
What does Orkla India IPO GMP today signal & caveats?
What the higher GMP suggests
- Investors in unofficial (grey) market anticipate that the listing price will be meaningfully above the issue price.
- It reflects strong aftermarket expectation/optimism in the IPO.
- It may also reflect excess demand vs supply, improving listing chances.
But remember the caveats
- Grey market is unregulated; GMP numbers are not official, may lack transparency or reliability.
- GMP is not a guarantee of actual listing gain — the stock could list at a different price depending on actual demand, market conditions, etc.
- Because it’s an OFS (no fresh issue) many shares are being sold by existing shareholders — implications for long-term valuations differ.
- Listing gains are just one facet; long-term fundamentals, company growth, valuation matter.
What Are the Key Dates for Orkla India IPO 2025?
| Particulars | Details |
|---|---|
| IPO Open Date | 29 October 2025 |
| IPO Close Date | 31 October 2025 |
| IPO Allotment Date | 3 November 2025 |
| Refund Date | 4 November 2025 |
| Demat Credit Date | 4 November 2025 |
| Listing Date | 6 November 2025 (BSE & NSE) |
| IPO Bidding Cutoff Time | 5 PM, 31 October 2025 |
What Are the Market Lot & Application Sizes?
| Investor Type | Lot Size | No. of Shares | Amount (₹) |
|---|---|---|---|
| Retail Min | 1 | 20 | 14,600 |
| Retail Max | 13 | 260 | 1,89,800 |
| S-HNI Min | 14 | 280 | 2,04,400 |
| B-HNI Min | 69 | 1,380 | 10,07,400 |
Final Thoughts
Given the data:
- The GMP level (~₹66) suggests a steady listing expectation, possibly listing at ~₹796 if upper band ₹730 holds.
- However, the range of GMP suggests volatility and that the premium is still moving; one should watch until closer to listing.
- If you are considering applying: Factor in the strong brand, but also remember: market may already “price in” the listing gain, leaving less upside.
- Retail investors should consider the valuation (P/E, growth prospects) and not just hunt for listing gain.
Orkla India IPO FAQs
Q1. What is the issue price band for the Orkla India IPO?
A1. ₹695 to ₹730 per share.
Q2. What is the minimum investment (lot size) for retail investors?
A2. 20 shares (i.e., at upper band ~₹14,600).
Q3. What is the Orkla India IPO GMP today?
A3. Orkla India IPO GMP today stands around ₹66 (9.04% premium)
Q4. What does GMP imply about listing gains?
A4. Roughly: issue band upper ₹730 + GMP = estimated listing price. For example, if GMP ~₹66 then implied listing ~₹796, meaning ~9.04% listing gain.
Q5. Is the issue a fresh issue or offer for sale?
A5. It’s an Offer for Sale (OFS) entirely – existing shareholders are selling shares; the company is not raising fresh capital.
Q6. Should I rely purely on GMP to decide whether to apply?
A6. No. GMP is only one indicator of short-term listing potential. You must also assess the company’s fundamentals, valuation, long-term prospects, lock-in terms, market conditions.
Click Here to know more market & IPO related updates and news.
Disclaimer: The views and investment insights provided here are based on publicly available information and do not constitute financial advice. Readers are advised to conduct their own research or consult certified financial experts before making investment decisions.
